Indeed, the increased CD147 glycosylation observed in adipocytes in response to HG and CML treatment was significantly nullified when MGAT5 was downregulated (Figure 4C). This evidence concerns the gene MGAT5 and chronic myelogenous leukemia, BCR-ABL1 positive.